INTERNATIONAL PATENT: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED FILES APPLICATION FOR "BENZOTHIADIAZINE DERIVATIVES AS MRGX2 ANTAGONISTS"

GENEVA, Feb. 17 -- GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GSK Medicines Research CentreGunnels Wood RoadStevenage SG1 2NY) filed a patent application (PCT/EP2025/072697) for "BENZOTHIADIAZINE DERIVATIVES AS MRGX2 ANTAGONISTS" on Aug 06, 2025. With publication no. WO/2026/033047, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AXTEN, Jeffrey Michael (GSK1250 South Collegeville RoadCollegeville, Pennsylvania 19426), EVANS, Karen Anderson (GSK1250 South Collegeville RoadCollegeville, Pennsylvania 19426), ...